| Literature DB >> 17878929 |
Christopher J Martyniuk1, Stéphane Aris-Brosou, Guy Drouin, Joel Cahn, Vance L Trudeau.
Abstract
BACKGROUND: The amino acid neurotransmitter GABA is abundant in the central nervous system (CNS) of both invertebrates and vertebrates. Receptors of this neurotransmitter play a key role in important processes such as learning and memory. Yet, little is known about the mode and tempo of evolution of the receptors of this neurotransmitter. Here, we investigate the phylogenetic relationships of GABA receptor subunits across the chordates and detail their mode of evolution among mammals. PRINCIPALEntities:
Mesh:
Substances:
Year: 2007 PMID: 17878929 PMCID: PMC1975676 DOI: 10.1371/journal.pone.0000894
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Phylogeny of GABA receptor protein sequences.
The two clades, based on the presence (α, γ, and ε) or absence (ρ, β, δ, θ, and π) of a benzodiazepine binding site, are indicated by BZ+ and BZ–, respectively. Bootstrap values (maximum likelihood analysis) are indicated at all nodes while posterior probabilities (Bayesian analysis) are only indicated when smaller than 100%. The scale bar represents 1 amino acid substitutions per site. Ach: acetylcholine receptor.
Figure 2Phylogeny of vertebrate GABA receptor protein sequences with benzodiazepine binding sites.
Bootstrap values are indicated at the nodes and the scale bar represents 1 amino acid substitutions per site.
Figure 3Phylogeny of vertebrate GABA receptor protein sequences without benzodiazepine binding sites.
Bootstrap values are indicated at the nodes and the scale bar represents 1 amino acid substitutions per site.
Model comparisons and parameter estimates under models of constant (H0) or variable ω rate ratios across branches (Br), clades (H1 to H3) or both clades and sites (A and B) for the θ subunit.
| Model |
| HA |
| Parameter estimates | Positively selected sites |
| H0 | −8978.84 | – | – |
| None |
| Br | −8903.32 | H0 | <0.0001 | – | N/A |
| H1 | −8976.36 | H0 | 0.0262 |
| N/A |
| A0 | −8958.66 | – | – |
| N/A |
|
| |||||
| A | −8952.09 | A0 | 0.0003 |
| (R24N), ({VA}135H), T143C, G224M, Y238R, P253I, |
|
| |||||
| B0 | −8861.57 | – | – |
| None |
| B | −8852.74 | B0 | 0.0001 |
| M185L, |
|
| |||||
| H2 | −8924.96 | H0 | <0.0001 |
| N/A |
| H3 | −8922.42 | H0 | <0.0001 |
| N/A |
|
|
Notes–ℓ: log-likelihood value; HA: alternative hypothesis to the current model; ω 0: background rate; ω 1–5: branch/clade specific rates as indicated in Figure 4; p 0–2: proportions of sites in each rate category. The hat notation indicates parameters that are free to vary. Positively selected sites were identified with BEB and NEB between brackets for model A and NEB only for model B; a 99% cut-off level of posterior probability was used. Sites putatively under positive selection are numbered according to the human θ reference sequence (accession number BC109210/AAI09211). The underlined sites are those common to both model A and model B. Curly braces indicate equally parsimonious ancestral sites.
Model comparisons and parameter estimates under models of constant (H0) or variable ω rate ratios across branches (Br), clades (H1 to H3) or both clades and sites (A and B) for the ε subunit.
| Model |
| HA |
| Parameter estimates | Positively selected sites |
| H0 | −9978.72 | – | – |
| None |
| Br | −9873.60 | H0 | <0.0001 | – | N/A |
| H1 | −9976.94 | H0 | 0.0592 |
| N/A |
| M1a | −9932.48 | – | – |
| N/A |
| A0 | −9922.54 | – | – |
| N/A |
|
| |||||
| A | −9921.96 | M1a | <0.0001 |
| {AG}206S, |
| A0 | 0.2778 |
| |||
| B0 | −9788.58 | – | – |
| None |
| B | −9787.81 | B0 | 0.4615 |
| ( |
|
| |||||
| H2 | −9909.20 | H0 | <0.0001 |
| None |
| H3 | −9896.02 | H0 | <0.0001 |
| None |
|
|
Notes–ℓ: log-likelihood value; HA: alternative hypothesis to the current model; ω 0: background rate; ω 1–5: branch/clade specific rates as indicated in Figure 4; p 0–2: proportions of sites in each rate category. The hat notation indicates parameters that are free to vary. Positively selected sites were identified with BEB and NEB between brackets for model A and NEB only for model B; a 95% cut-off level of posterior probability was used. Sites putatively under positive selection are numbered according to the human ε reference sequence (accession numbers HSU66661/AAB49284). †: these sites were putatively identified with a posterior probability >50% (see text). The underlined sites are those common to both model A and model B. Curly braces indicate equally parsimonious ancestral sites.
Figure 4Phylogenetic trees used to formulate hypotheses about the selective forces that shaped the evolution of the GABAA subunits.
(a) the GABAA receptor θ and β subunits ; (b) the GABAA receptor ε and γ subunits. Selective pressures are allowed to vary among sets of branches to test for the a priori hypotheses listed at the bottom of the figure: H0: the null hypothesis that all branch-specific rates are equal; H1: burst of evolution following the main gene duplication event (ε/γ and θ/β); H2: also allows for a rate change after the burst of evolution; H3: extends H2 to allow for burst of evolution after all duplication events depicted on each tree. Hypotheses test are reported in Tables 1 and 2. The scale bar represents 0.1 substitutions per codon site, with branch lengths estimated under the null model (H0).
Figure 5Mapping of the sites putatively under positive selection on the three-dimensional models of the θ subunit of the GABAA receptor.
Sites putatively detected to be under positive selection on subunit θ under: (a) model A and (b) model B.